Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study.
Diabetol Metab Syndr
; 10: 75, 2018.
Article
en En
| MEDLINE
| ID: mdl-30349614
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Año:
2018
Tipo del documento:
Article